WASHINGTON, July 6 -- Food and Drug Administration has issued a notice called: Expedited Investigational New Drug Pilot Program; Request for Information; Correction.
The notice was published in the Federal Register on July 6 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Registerof June 24, 2026. That notice opened a public docket to solicit input and comments on a proposal to establish a pilot program, the Expedited Investigational New Drug pilot program, to shorten the time it takes from drug identification to first-in-human study, while protecting clinical trial participants. FDA is correcting...